Chronic autoimmune (AI) and inflammatory diseases (IDs) such as rheumatoid arthritis are severe and devastating pathological conditions. Developing novel therapeutic strategies for such diseases is a highly important research priority.
Src-family kinases (SFKs) recently emerged as major therapeutic targets in malignant diseases, but their suitability as potential targets of AI and IDs have not been investigated in depth. SFKs are non-receptor tyrosine kinases implicated in diverse biological functions such as cellular proliferation and invasion.
Further details: Anticancer drugs for chronic inflammation